Ghosh; Malay

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ghosh; Malay.The latest application filed is for "pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same".

Company Profile

3.11.26

Ghosh; Malay - Fort Worth TX
Ghosh; Malay - Forth Worth TX
- Fort Worth TX US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compositions Of Lipoic Acid Choline Ester Salts And Methods Of Treatment Using Same App 20210393671 - Bucher; Christoph ; et al.	2021-12-23
Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same Grant 11,135,239 - Bucher , et al. October 5, 2	2021-10-05
Pharmaceutical Compositions Of Lipoic Acid Choline Ester Salts And Methods Of Treatment Using Same App 20210283171 - Bucher; Christoph ; et al.	2021-09-16
Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease Grant 10,174,006 - Ghosh , et al. J	2019-01-08
Compositions For Treating Microbial Infections App 20170333441 - Ghosh; Malay ; et al.	2017-11-23
Carboxylvinyl polymer-containing nanoparticle suspensions Grant 9,662,398 - Chowhan , et al. May 30, 2	2017-05-30
High Concentration Olopatadine Ophthalmic Composition App 20170071895 - Gamache; Daniel A. ; et al.	2017-03-16
Carboxylvinyl Polymer-containing Nanoparticle Suspensions App 20170020818 - Chowhan; Masood A. ; et al.	2017-01-26
High concentration olopatadine ophthalmic composition Grant 9,533,053 - Gamache , et al. January 3, 2	2017-01-03
Finafloxacin suspension compositions Grant 9,504,691 - Boudreaux , et al. November 29, 2	2016-11-29
Finafloxacin Suspension Compositions App 20160279137 - Boudreaux; Brent G. ; et al.	2016-09-29
Phospholipid Compositions for Contact Lens Care and Preservation of Pharmaceutical Compositions App 20150209466 - Ghosh; Malay ; et al.	2015-07-30
Compositions For Treating Microbial Infections App 20150174137 - Ghosh; Malay ; et al.	2015-06-25
Carboxylvinyl Polymer-containing Nanoparticle Suspensions App 20150072011 - CHOWHAN; Masood A. ; et al.	2015-03-12
Carboxyvinyl polymer-containing nanoparticle suspensions Grant 08921337 -	2014-12-30
Carboxyvinyl polymer-containing nanoparticle suspensions Grant 8,921,337 - Chowhan , et al. December 30, 2	2014-12-30
Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye Grant 8,912,236 - Kabra , et al. December 16, 2	2014-12-16
Topical Aqueous Ophthalmic Compositions Containing A 1h-indole-1-carboxamide Derivative And Use Thereof For Treatment Of Ophthalmic Disease App 20140364392 - Ghosh; Malay ; et al.	2014-12-11
High Concentration Olopatadine Ophthalmic Composition App 20140296328 - Gamache; Daniel A. ; et al.	2014-10-02
High concentration olopatadine ophthalmic composition Grant 8,791,154 - Gamache , et al. July 29, 2	2014-07-29
Finafloxacin Suspension Compositions App 20140162990 - Boudreaux; Brent G. ; et al.	2014-06-12
Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye App 20130137741 - Kabra; Bhagwati P. ; et al.	2013-05-30
High Concentration Olopatadine Ophthalmic Composition App 20120295967 - Gamache; Daniel A. ; et al.	2012-11-22
Ophthalmic Composition With A Viscosity Enhancement System Having Two Different Viscosity Enhancing Agents App 20120269862 - Chowhan; Masood A. ; et al.	2012-10-25
Ophthalmic Composition With A Viscosity Enhancement System Having Two Different Viscosity Enhancing Agents App 20120270955 - Chowhan; Masood A. ; et al.	2012-10-25
Pharmaceutical Composition With Enhanced Solubility Characteristics App 20120022149 - Chowhan; Masood A. ; et al.	2012-01-26
Carboxyvinyl Polymer-containing Nanoparticle Suspensions App 20110135743 - Chowhan; Masood A. ; et al.	2011-06-09
Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye App 20100227905 - Kabra; Bhagwati P. ; et al.	2010-09-09
Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye App 20100227904 - Kabra; Bhagwati P. ; et al.	2010-09-09
Pharmaceutical Composition Having Relatively Low Ionic Strength App 20100056537 - Ghosh; Malay ; et al.	2010-03-04
Self-preserved Emulsions App 20090298956 - Chowhan; Masood A. ; et al.	2009-12-03
Phospholipid Compositions for Contact Lens Care and Preservation of Pharmaceutical Compositions App 20080287395 - Ghosh; Malay ; et al.	2008-11-20
PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE App 20070148225 - WEINER; Alan L. ; et al.	2007-06-28
PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE App 20070149480 - Ghosh; Malay ; et al.	2007-06-28
PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE App 20070149593 - Ghosh; Malay ; et al.	2007-06-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.